Flyer Value Dossier

5 Target groups and fields of application for the Value Dossier EbM - based For all new products, for the introduction of new indications and for the introduction of new dosage forms, the Value Dossier EbM - based is a must today. For all successful, established pro- ducts, the Value Dossier EbM - based can help to inform payers, service providers and health po- licy decision - makers "stakeholders" quickly and compactly about the scientific basis of the product. The Value Dossier EbM - based is the knowledge base for the product and at the same time the reassurance of the product for the critical phases in the lifecycle. Use of the Value Dossier EbM - based • For statements for IQWIG, the G - BA and the SpiBu • In statements for the DIMDI • In discussions with the InEK • In discussions with the health insurance funds • In discussions with the MDK / MDS • For drug commissions in hospitals (listing) • During key account discussions • During negotiations for innovative direct contracts (140 A ff SGB V) • At scientific symposia • At introductory conferences • During product training • During license negotiations Target groups for communication with the Value Dossier EbM - based Service provider Payer Stakeholder Partner / internal